Walker Marlan D 4
4 · TherapeuticsMD, Inc. · Filed Dec 7, 2023
Insider Transaction Report
Form 4
Walker Marlan D
Chief Executive Officer
Transactions
- Sale
Common Stock
2023-12-07$2.24/sh−4,550$10,187→ 62,565 total - Exercise/Conversion
Restricted Stock Units
2023-12-05−70,000→ 0 totalExercise: $0.00→ Common Stock (70,000 underlying) - Exercise/Conversion
Common Stock
2023-12-05+70,000→ 81,615 total - Sale
Common Stock
2023-12-06$2.31/sh−14,500$33,496→ 67,115 total
Footnotes (4)
- [F1]The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $2.22 through $2.48, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $2.15 through $2.31, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth.
- [F4]Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in full on June 30, 2023.